Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
ASO Visual Abstract: Secondary Cytoreductive Surgery ± Hyperthermic Intraperitoneal Chemotherapy for Recurrent Colorectal Cancer Peritoneal Metastases.
Journal: Annals of surgical oncology
Published: August 17, 2026
Comparative Analysis of Characteristics and Outcomes of Patients with Early-Onset Versus Average-Onset Small Bowel Neuroendocrine Tumors.
Journal: American journal of clinical oncology
Published: August 06, 2026
Optimal duration of neoadjuvant chemotherapy prior to CRS ± HIPEC for colorectal cancer: An assessment of survival and postoperative outcomes.
Journal: Surgical oncology insight
Published: April 27, 2026
Robust response to pembrolizumab in temozolomide-associated hypermutated and microsatellite instability-high functional pancreatic neuroendocrine tumor.
Journal: The oncologist
Published: April 12, 2026
Secondary Cytoreductive Surgery ± Hyperthermic Intraperitoneal Chemotherapy for Recurrent Colorectal Cancer Peritoneal Metastases.
Journal: Annals of surgical oncology
Published: March 24, 2026
Grade Progression and High-Grade Transformation in Neuroendocrine Neoplasms.
Journal: Endocrine-related cancer
Published: January 13, 2026
Primary tumor resection in the setting of unresectable metastatic disease in small bowel NETs: consensus and controversy.
Journal: Endocrine-related cancer
Published: November 24, 2025
Primary tumor resection in the setting of unresectable metastatic disease in small bowel NETs: consensus and controversy.
Journal: Endocrine-related cancer
Published: November 24, 2025
Differential Effects of HDAC6 Inhibition Versus Knockout During Hepatic Ischemia-Reperfusion Injury Highlight Importance of HDAC6 C-terminal Zinc-finger Ubiquitin-binding Domain.
Journal: Transplantation
Published: April 30, 2024
Consensus Guideline for the Management of Peritoneal Metastases from Neuroendocrine Neoplasms.
Journal: Annals of surgical oncology
Published: April 18, 2024
Effect of Minimally Invasive Gastrectomy on Return to Intended Oncologic Therapy for Gastric Cancer.
Effect of Minimally Invasive Gastrectomy on Return to Intended Oncologic Therapy for Gastric Cancer.
Journal: Annals of surgical oncology
Published: April 15, 2024
Last Updated: 09/26/2026